We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

193 hedge funds and large institutions have $1.24B invested in Collegium Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 58 increasing their positions, 77 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

154% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 13

43% more capital invested

Capital invested by funds: $865M → $1.24B (+$373M)

12.06% more ownership

Funds ownership: 111.28% → 123.34% (+12%)

11% more funds holding

Funds holding: 174 → 193 (+19)

25% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 77

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

86% less call options, than puts

Call options by funds: $305K | Put options by funds: $2.15M

Holders
193
Holders Change
+19
Holders Change %
+10.92%
% of All Funds
2.81%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
33
Increased
58
Reduced
77
Closed
13
Calls
$305K
Puts
$2.15M
Net Calls
-$1.85M
Net Calls Change
-$790K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$35.4M
2
Pacer Advisors
Pacer Advisors
Pennsylvania
+$22.1M
3
PCM
Penn Capital Management
Pennsylvania
+$7.91M
4
Invesco
Invesco
Georgia
+$7.06M
5
Renaissance Technologies
Renaissance Technologies
New York
+$5.31M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$11.4M
2
RCMNY
Rubric Capital Management (New York)
New York
-$10.4M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$6.33M
4
Marshall Wace
Marshall Wace
United Kingdom
-$6.27M
5
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
-$5.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
51
Ameriprise
Minnesota
$3.12M -$372K -14,834 -13%
MOACM
52
Mutual of America Capital Management
New York
$3.08M -$536K -21,389 -18%
TI
53
Trexquant Investment
Connecticut
$2.91M -$962K -38,402 -29%
HIM
54
Hillsdale Investment Management
Ontario, Canada
$2.9M -$5.01K -200 -0.2%
Legal & General Group
55
Legal & General Group
United Kingdom
$2.88M -$110K -4,395 -4%
N
56
Nuveen
North Carolina
$2.84M +$23.1K +922 +1%
TAM
57
Third Avenue Management
New York
$2.56M +$2.08M +83,120 New
Barclays
58
Barclays
United Kingdom
$2.24M +$830K +33,139 +84%
CSS
59
Cubist Systematic Strategies
Connecticut
$2.23M -$146K -5,826 -7%
Los Angeles Capital Management
60
Los Angeles Capital Management
California
$2.17M -$159K -6,350 -8%
American Century Companies
61
American Century Companies
Missouri
$2.14M +$580K +23,166 +50%
Swiss National Bank
62
Swiss National Bank
Switzerland
$2.11M -$190K -7,600 -10%
Public Sector Pension Investment Board (PSP Investments)
63
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.08M +$620K +24,745 +58%
State of Wisconsin Investment Board
64
State of Wisconsin Investment Board
Wisconsin
$1.87M +$834K +33,277 +121%
National Bank of Canada
65
National Bank of Canada
Quebec, Canada
$1.86M +$1.49M +59,400 New
Man Group
66
Man Group
United Kingdom
$1.72M +$1.4M +55,979 New
Royal Bank of Canada
67
Royal Bank of Canada
Ontario, Canada
$1.57M +$193K +7,722 +18%
CS
68
Credit Suisse
Switzerland
$1.53M +$44.8K +1,788 +4%
EIP
69
Easterly Investment Partners
Massachusetts
$1.53M – – –
HF
70
HRT Financial
New York
$1.5M -$1.08M -42,924 -47%
AFAS
71
Acorn Financial Advisory Services
Virginia
$1.44M -$34.5K -1,377 -3%
Allspring Global Investments
72
Allspring Global Investments
North Carolina
$1.41M +$105K +4,192 +10%
GAM
73
Gotham Asset Management
New York
$1.38M +$47.6K +1,899 +4%
GC
74
Globeflex Capital
California
$1.36M – – –
Susquehanna International Group
75
Susquehanna International Group
Pennsylvania
$1.25M +$786K +31,382 +336%
1 2
3
4 5

COLL Hedge Fund Activity: Q4 2023 in Review

193 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2023, worth a combined $1.24B — up 43% from $865M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new COLL positions and 13 closed out — a net gain of 20 holders — while 58 added to existing stakes and 77 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $35.4M. The largest seller was BlackRock, cutting an estimated $11.4M.

  • 193 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2023, up from 174 in Q3 2023.
  • Funds reported $1.24B of Collegium Pharmaceutical stock for Q4 2023, up 43% quarter-over-quarter.
  • 33 funds opened new Collegium Pharmaceutical positions in Q4 2023 and 13 closed out, a net change of +20 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2023 was Morgan Stanley, an estimated $35.4M added.
  • The largest Collegium Pharmaceutical seller in Q4 2023 was BlackRock, an estimated $11.4M sold.

Based on aggregated 13F filings for Q4 2023.